echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > FDA Fast Track Designation for Innovative Cell Therapy for HPV16-Positive Solid Tumors

    FDA Fast Track Designation for Innovative Cell Therapy for HPV16-Positive Solid Tumors

    • Last Update: 2022-05-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Cube Info

    Author: Pickup

    On April 27, SQZ Biotechnologies announced that the U.


    Human papillomavirus (HPV) is one of the most common viruses in the world, and some strains can live in the body for many years, often causing cancer


    SQZ-PBMC-HPV is based on the company's technology platform called "Cell Squeeze"


    SQZ-PBMC-HPV is developed based on the company's SQZ® APCs platform, which induces a specific T cell response against the antigen by encapsulating the target antigen in APC cells


    Data presented at the 2021 ESMO Immuno-Oncology Congress showed that SQZ-PBMC-HPV monotherapy induced radiographic, symptomatic, and immune responses in immune checkpoint PD-1-treated patients with HPV16-positive solid tumors


    SQZ-PBMC-HPV is currently being evaluated in a Phase I/II clinical trial for the treatment of patients with HPV16+ advanced or metastatic solid tumors positive for human leukocyte antigen serotype HLA-A*02


    Note: The original text has been deleted

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.